Viewing Study NCT04802733


Ignite Creation Date: 2025-12-25 @ 2:45 AM
Ignite Modification Date: 2025-12-26 @ 1:25 AM
Study NCT ID: NCT04802733
Status: COMPLETED
Last Update Posted: 2024-11-01
First Post: 2021-03-12
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase 1 Safety and Tolerability Study of MSK-DA01 Cell Therapy for Advanced Parkinson's Disease
Sponsor: BlueRock Therapeutics
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module